High yield bacterial expression of active c-Abl and c-Src tyrosine kinases. - Wikidata - wikimedia - TriplyDB

High yield bacterial expression of active c-Abl and c-Src tyrosine kinases.

High yield bacterial expression of active c-Abl and c-Src tyrosine kinases.

http://www.wikidata.org/entity/Q30160084

about

Structural basis for the recognition of c-Src by its inactivator Csk c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease Phosphorylation of LRP1 regulates the interaction with Fe65 Highly specific, bisubstrate-competitive Src inhibitors from DNA-templated macrocycles Structural and functional consequences of tyrosine phosphorylation in the LRP1 cytoplasmic domain Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation A conserved protonation-dependent switch controls drug binding in the Abl kinase Phosphorylation and activation of a transducible recombinant form of human HSP20 in Escherichia coli Comparative Analysis of Mutant Tyrosine Kinase Chemical Rescue † ‡Equally Potent Inhibition of c-Src and Abl by Compounds that Recognize Inactive Kinase Conformations Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors Intersubunit capture of regulatory segments is a component of cooperative CaMKII activation Active site profiling reveals coupling between domains in SRC-family kinases Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK Multiple Determinants for Selective Inhibition of Apicomplexan Calcium-Dependent Protein Kinase CDPK1 Structural and Spectroscopic Analysis of the Kinase Inhibitor Bosutinib and an Isomer of Bosutinib Binding to the Abl Tyrosine Kinase Domain A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity A genetically encoded 19F NMR probe for tyrosine phosphorylation Crystal structure of an SH2-kinase construct of c-Abl and effect of the SH2 domain on kinase activity Design, synthesis and biological evaluation of novel FGFR inhibitors bearing an indazole scaffold Structural and Biochemical Basis for Intracellular Kinase Inhibition by Src-specific Peptidic Macrocycles Dynamically Coupled Residues within the SH2 Domain of FYN Are Key to Unlocking Its Activity A Src-like inactive conformation in the abl tyrosine kinase domain Allosteric interactions between the myristate- and ATP-site of the Abl kinase Biochemical and functional studies of lymphoid-specific tyrosine phosphatase (Lyp) variants S201F and R266W Rbx2 regulates neuronal migration through different cullin 5-RING ligase adaptors c-Src binds to the cancer drug Ruxolitinib with an active conformation Autoinhibition of Bruton's tyrosine kinase (Btk) and activation by soluble inositol hexakisphosphate.Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.A Discovery Strategy for Selective Inhibitors of c-Src in Complex with the Focal Adhesion Kinase SH3/SH2-binding Region.SH2-catalytic domain linker heterogeneity influences allosteric coupling across the SFK family.Differential sensitivity of Src-family kinases to activation by SH3 domain displacement.Divergent modulation of Src-family kinase regulatory interactions with ATP-competitive inhibitors.Abl kinase constructs expressed in bacteria: facilitation of structural and functional studies including segmental labeling by expressed protein ligation Phosphorylation of a PDZ domain extension modulates binding affinity and interdomain interactions in postsynaptic density-95 (PSD-95) protein, a membrane-associated guanylate kinase (MAGUK).3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions Bivalent inhibitors of the tyrosine kinases ABL and SRC: determinants of potency and selectivity Identification of N-terminal lobe motifs that determine the kinase activity of the catalytic domains and regulatory strategies of Src and Csk protein tyrosine kinases.Profiling Subcellular Protein Phosphatase Responses to Coxsackievirus B3 Infection of Cardiomyocytes.A research-inspired laboratory sequence investigating acquired drug resistance.

P2860

Q24311447-A8C24F02-BCF1-4D40-BF96-0609D10054A9 Q24318974-3C49C92F-7E5F-481E-84CC-88CADC1B9811 Q24339385-B016C8C4-8AE7-4089-B924-848F762ED7F6 Q24614202-36B6E0E4-ECEE-4B25-8811-141F3B326BE6 Q24644020-3D5AB7C1-7A04-4C08-B7CA-2CAF6CFB9C77 Q24648477-F851304C-9C57-4F07-9387-4CFAE77E7B00 Q24657421-44A6B3DA-6908-4002-8919-540725AA8583 Q24672847-8A622DA3-A2F7-42FC-ACAD-326248F2C986 Q27654012-EC53FDC0-AEA9-4B97-A629-E5CC6848C37B Q27654059-029F88B7-6053-4425-B016-829E8A86CFDA Q27658951-3671944C-20FF-4B96-B831-A55BDAF4E657 Q27659633-87B45561-C0D6-4885-AB2F-B52DC9EECDBC Q27675080-BB87DC46-68E9-467B-8900-6C4F4369D7E4 Q27677302-FC95D9DB-AF48-4DB7-8BC8-D70D434BCFB5 Q27677507-215E8CAB-8B07-4015-BEC4-01ADCFFCC276 Q27678454-7F7842E8-E78E-440D-B0EB-57CFCAE7EE47 Q27680722-2581EA81-913B-4EDE-878F-CE978B2C909F Q27684095-0053C344-C4DA-4034-9498-0C21164635F7 Q27698513-6621BE59-2084-411B-BE89-529D49029FB5 Q27701029-E65EB02B-0F39-4BB0-AFE4-7A94B23C0189 Q27727987-CEBD60E1-D8F1-4C02-8DAC-3A44419A0777 Q27728152-38EDE388-92C2-42C5-BF56-30F4804276A3 Q28469170-D3187F74-0C70-4942-988B-46F25C1326BF Q28476718-648A107A-BEFC-43C1-8146-0EEB689DFC09 Q28482717-B2B01E28-5D8C-473C-AF8F-AFC0E28C4DFD Q28507618-1DFE8F2E-BC97-4FC7-A61F-D3D461DDFFF0 Q28542851-5B5BD939-F610-4C96-815A-31CDDBCDA750 Q30009224-C8CAC11F-CFA7-4B53-87FC-81B141934EA7 Q30009282-6DEFB6D8-A91D-468D-AB2E-A231B7C53F45 Q30009284-E941E6EC-A22F-4534-912E-616ABDCD6316 Q30009300-D15819EE-E7B0-434C-9C38-49A544EB3C33 Q30009328-57A1B66D-9BE1-45F3-B8D6-51A64E2F8CB0 Q30009417-0647ABFC-F72F-493E-843A-A4F6AB9117D8 Q30010105-49309FF2-4D87-4E42-896D-64708B2D26AD Q30010229-5BE9E149-2345-490F-ABEF-BFD3DD1705A4 Q30010273-404D5866-AAED-446F-8266-47E9BC20BFA6 Q30155965-C86D53DD-29C2-4FC5-AFCA-C383419E0A14 Q30157342-103C2A5C-352D-4B52-A161-810EFF2E3753 Q30274823-B2DBBB40-5DF8-4FF1-B8BF-D01E5E371D8E Q30402618-89A8ED20-F1DE-48E6-9D4C-40331E545CF3

P2860

High yield bacterial expression of active c-Abl and c-Src tyrosine kinases.

http://www.wikidata.org/entity/Q30160084

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

High yield bacterial expression of active c-Abl and c-Src tyrosine kinases.

@ast

High yield bacterial expression of active c-Abl and c-Src tyrosine kinases.

@en

type

label

High yield bacterial expression of active c-Abl and c-Src tyrosine kinases.

@ast

High yield bacterial expression of active c-Abl and c-Src tyrosine kinases.

@en

prefLabel

High yield bacterial expression of active c-Abl and c-Src tyrosine kinases.

@ast

High yield bacterial expression of active c-Abl and c-Src tyrosine kinases.

@en

P1433

Q30160084-D2A5E5C2-6C11-4F52-9C04-3E5AC8955F9C

P1476

Q30160084-B4EC8204-5A09-4283-B6D6-EA46D443F26D

P2093

Q30160084-0D7A8F90-FF0F-4D49-BFAA-337D3063C45F

Q30160084-D7FA1AAE-1C0D-497A-943F-F45121132752

Q30160084-DDE6AF37-F05A-4B1F-8040-BC7954BDE671

Q30160084-F1163884-9D95-4E75-B922-CD86B65B7D12

P2860

Q30160084-116F0AF1-561F-45A9-91FF-D8E987755154

Q30160084-17423A38-8278-4B4C-B8B2-43ABB2307B5B

Q30160084-3FB964D9-562C-4D02-99F9-2F8EFD21B313

Q30160084-469E338D-8C95-4500-B843-3F9E6048A4F1

Q30160084-579CB014-D9A4-4B43-86ED-96BE5561A941

Q30160084-701B8B91-BFB3-4835-A9EB-E97ADBD997F7

Q30160084-80B3D0EF-9926-4528-BA41-DF3EECD62FC6

Q30160084-821BBE28-F581-4E12-A80F-91576968844D

Q30160084-88799B20-0D74-4E19-8F61-06F72AE40FD8

Q30160084-CEB1436B-20E0-4315-A747-39567EEC2D4D

P304

Q30160084-CA27A335-A269-47B1-92C2-EB012A56E311

P31

Q30160084-8CCD85AA-FBBF-4E64-9878-0F53D6E3B031

P356

Q30160084-C61D8AED-76C9-491C-805F-ED90F080A303

P433

Q30160084-14312BB1-D7F9-4182-89E3-1D68380858A6

P478

Q30160084-7348FF06-D36B-40CC-9D27-2BD2C62F1702

P50

Q30160084-2E684613-729D-4C59-A8BC-630CB6B00FA9

Q30160084-348C5892-B85B-45BA-919B-011EE215C11B

Q30160084-BDBB4D0C-DCAD-4883-9E21-0149A7499284

P577

Q30160084-613A7741-3E3C-4C1C-ADC2-071C502C9837

P5875

Q30160084-497C9E75-EF10-4A6F-84BE-B8859BF4D677

P698

Q30160084-5007DB38-B6B9-4F16-AC6C-DC5C4808370A

P932

Q30160084-A6D1A746-F2AE-4911-B595-AB2BF1714ADC

P356

P1433

Protein Science

P1476

High yield bacterial expression of active c-Abl and c-Src tyrosine kinases.

@en

P2093

Arnold M Falick

http://www.w3.org/2001/XMLSchema#string

David S King

http://www.w3.org/2001/XMLSchema#string

M Nidanie Henderson

http://www.w3.org/2001/XMLSchema#string

Patricia Pellicena

http://www.w3.org/2001/XMLSchema#string

P2860

Nucleotide sequence of testis-derived c-abl cDNAs: implications for testis-specific transcription and abl oncogene activation

Structural basis for the autoinhibition of c-Abl tyrosine kinase

Crystal structure of the Src family tyrosine kinase Hck

The Abl family kinases: mechanisms of regulation and signaling

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

Cellular functions regulated by Src family kinases

Metal chelate affinity chromatography, a new approach to protein fractionation.

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug.

Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus.

P304

3135-3139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1110/PS.051750905

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Markus A Seeliger

P577

2005-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7505930

http://www.w3.org/2001/XMLSchema#string

P698

16260764

http://www.w3.org/2001/XMLSchema#string

P932

2253236

http://www.w3.org/2001/XMLSchema#string